Theranostic Lipid Nanoparticles in Cancer Nanomedicine – Insights from Dr. Gang Zheng’s BOC Sciences Webinar

mybcs
Introduction: The Next Frontier of Lipid Nanoparticles (LNPs) in Cancer Nanomedicine For decades, cancer nanomedicine has pursued a central goal — to deliver potent therapies directly to tumors while sparing healthy tissues. Lipid nanoparticles (LNPs) have emerged as one of the most clinically validated nanocarriers, from mRNA delivery to small-molecule encapsulation. Yet, a new generation of lipid-based technologies is pushing the boundaries even further: theranostic lipid nanoparticles,...